Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | M-CSF | 136.0 | 55 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | M-CSF | 107.0 | 89 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | M-CSF | 86.0 | 52 | |
N2586 | IL-17A | 100 | ng/mL | 3 | M-CSF | 190.0 | 73 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | M-CSF | 180.5 | 76 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | M-CSF | 137.5 | 60 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | M-CSF | 295.0 | 77 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | M-CSF | 130.5 | 64 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | M-CSF | 128.0 | 65 | |
RA2159 | IL-6 | 100 | ug/mL | 3 | M-CSF | 87.0 | 53 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | M-CSF | 97.0 | 70 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | M-CSF | 82.5 | 74 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | M-CSF | 101.5 | 58 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | M-CSF | 100.0 | 80 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | M-CSF | 79.0 | 71 | |
RA2159 | Sigma A6730 | 3.0 | uM | 3 | M-CSF | 115.0 | 59 | ||||
N2586 | IL-6 | 100 | ug/mL | 3 | M-CSF | 224.0 | 77 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | M-CSF | 153.0 | 55 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | M-CSF | 126.0 | 54 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | M-CSF | 150.0 | 61 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | M-CSF | 140.0 | 75 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | M-CSF | 126.0 | 63 | |
N2586 | Sigma A6730 | 3.0 | uM | 3 | M-CSF | 154.0 | 65 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 233.0 | 80 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | M-CSF | 185.0 | 70 |